Clinical trials are an essential part of developing new medicines. For a new medicine to become available on prescription or over the pharmacy counter, it must be proven to be effective and safe.

Why do we have clinical trials?
Over 1,000 clinical trials are run every year in the UK. Roughly a third of these are early stage trials like the ones performed at Pharmaceutical Profiles.  In these trials small groups of healthy people help to assess various aspects of the test medicine such as how it is processed by the body, the effective dose levels, and what is the maximum amount that any one person should take before side effects are felt. 

The next step….
The next step is to test the medicine on patients. This helps us to assess whether the new medicine will help to alleviate their symptoms.   Trials like these are typically much larger – involving hundreds, sometimes thousands, of patients.

Clinical trials at Pharmaceutical Profiles
At Pharmaceutical Profiles, we perform early Phase I trials with small groups of 8-10 healthy volunteers at a time. The vast majority of our trials are with test medicines that have already been tested in people.  Some are already on sale.

There are several different types of trials that we do at Pharmaceutical Profiles:

1. Enterion Trials * (What is an Enterion? Click here for PDF)
2. Inhalation trials * (What is inhalation? Click here for PDF)
3. Microdosing trials * (What is microdosing?Click here for PDF)
4. PK trials * (What is PK? Click here for PDF)